3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
2
Plasma cell
1
Conditions
Neoplasms
7
Breast Neoplasms
7
Anxiety Disorders
6
Depression
4
Smoking Cessation
2
Lymphoma
2
Colorectal Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stress, Psychological
1
Stage III Gynecologic Cancer
1
Smoking
1
Skin Neoplasms
1
Psychological Well-Being
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parasomnias
1
Pain, Postoperative
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Motor Activity
1
Melanoma
1
Medically Unexplained Symptoms
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Inflammation
1
Hematopoietic and Lymphoid System Neoplasm
1
Interventions
Cyclophosphamide
25
Rituximab
18
fludarabine phosphate
15
Radiotherapy
13
Methotrexate
13
Peripheral Blood Stem Cell Transplantation
12
Filgrastim
12
Cytarabine
12
Vincristine
11
Melphalan
10
Cyclosporine
10
Busulfan
10
Antilymphocyte Serum
10
Exercise
9
Doxorubicin
9
Prednisone
7
Mycophenolic Acid
7
Magnetic Resonance Spectroscopy
7
Etoposide
7
Early Intervention, Educational
7
Whole-Body Irradiation
6
Surveys and Questionnaires
6
Prednisolone
6
Palliative Care
6
Methods
6
Leucovorin
6
Educational Status
6
Blood Specimen Collection
6
Dexamethasone
5
pegylated granulocyte colony-stimulating factor
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma
×
Mindfulness
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts
NCT02272751
2019-02-20
REIL
St George's, University of London
Phase NA
Completed
41 enrolled